Some conditions apply: Systems for studying Plasmodium falciparum protein function

Heather M Kudyba1, David W Cobb2,3, Joel Vega-Rodríguez1

  • 1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos Pathogens
|April 22, 2021
PubMed

Insights

New genetic tools allow scientists to study malaria-causing Plasmodium falciparum parasites more effectively. These advances in conditional knockdown systems are crucial for understanding parasite biology and developing new antimalarial drugs.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Genetics

Background:

  • Malaria remains a major global health issue, historically limited by challenges in studying the Plasmodium falciparum parasite.
  • Genetic manipulation and tools for studying essential parasite proteins and pathways were previously restricted.

Purpose of the Study:

  • To review common conditional knockdown systems adapted or developed for Plasmodium falciparum.
  • To highlight the application of these systems across the parasite's life cycle, including beyond intraerythrocytic stages.

Main Methods:

  • Review of existing literature on conditional knockdown systems in P. falciparum.
  • Focus on systems targeting gene expression, translation, and protein function.
  • Discussion of applications in asexual blood-stage and other parasite life stages.

Main Results:

  • Significant advancements in genetically manipulating P. falciparum and controlling protein function have been achieved.
  • Conditional knockdown systems targeting the central dogma components are now available.
  • These tools have been successfully applied to study parasite biology in various life stages.

Conclusions:

  • Conditional knockdown systems have revolutionized the study of P. falciparum biology.
  • Increased understanding of parasite pathways is leading to the discovery of new antimalarial drug targets.
  • These genetic tools are essential for future malaria research and drug development efforts.